In short

The prescribing information for these products addresses use during breastfeeding, and the available data is limited. There is no simple yes or no that.

By Alsen Walker · Updated September 22, 2026

The prescribing information for these products addresses use during breastfeeding, and the available data is limited. There is no simple yes or no that applies to everyone, which is why this needs a conversation with your prescriber and whoever is supporting your feeding rather than an answer from an article.

Do not restart on your own after delivery. The decision involves whether you are breastfeeding, how established feeding is, your own nutritional needs, and what you were being treated for. Ask before you inject.

Equally, if you are already taking it and breastfeeding, contact your prescriber rather than stopping feeding abruptly. Both parts of that need managing together.

For how this fits into stopping and maintenance generally, see Stopping a GLP-1: What Happens and How to Plan It.

What the uncertainty actually is

The question is whether the medication transfers into milk in meaningful amounts, and what effect any transfer would have on an infant. Data in humans is limited, which is common for medications in lactation because studies are difficult to conduct ethically.

Limited data means unresolved rather than dangerous, and it also means nobody can reassure you definitively. Both halves of that are true and both matter.

Check the lactation section of the prescribing information for your specific product, and go through it with your prescriber.

The nutritional side

This is the part people rarely consider and it is genuinely important.

Breastfeeding raises your energy and nutrient requirements substantially. A medication that suppresses appetite works directly against meeting them.

Inadequate intake while breastfeeding affects your own nutritional status, your energy, and potentially milk supply. If you are taking one of these medications while feeding, intake needs deliberate attention rather than being left to appetite, which is exactly what has been suppressed.

Weight after birth

Pressure to lose weight quickly after having a baby is intense and comes from every direction. It is worth naming that this pressure is not a clinical indication.

Postpartum weight management, if you want it, has a timeline that should be set with your clinician alongside recovery, feeding and sleep, rather than against social expectation.

If you were on treatment before pregnancy and want to resume, that is a legitimate conversation. It is also one where the timing matters.

If you have type 2 diabetes

Glycaemic control still needs managing while breastfeeding, and stopping one treatment usually means arranging another rather than nothing.

Make sure whoever manages your diabetes is involved in the feeding conversation rather than the two being handled separately.

Where to get better information

Your prescriber, your midwife or health visitor, and specialist medication-in-lactation information services, which exist in many countries specifically to answer questions like this.

These services deal with exactly this uncertainty daily and can give you something more useful than a general article can.

Frequently asked questions

Is it safe while breastfeeding?
Data is limited. Check the lactation section for your product and discuss it with your prescriber.

Can I pump and discard?
Whether that achieves anything depends on the medication’s behaviour, and it is not a general solution. Ask.

Should I stop breastfeeding to take it?
That is a significant decision with its own consequences and not one to make on the basis of an article.

When can I restart after birth?
Depends on feeding and your circumstances. Ask before resuming.

Will it affect my milk supply?
Reduced intake can affect supply. If you take it while feeding, intake needs deliberate attention.

Who else can advise?
Specialist medication-in-lactation information services, alongside your prescriber and midwife or health visitor.

Alsen Walker is a health writer and researcher at GLP1Hub with five years of experience researching and writing health and medical content. He works in a medical-field role alongside his undergraduate studies. At GLP1Hub he researches GLP-1 weight loss programs, pricing and insurance rules, and checks claims against FDA prescribing information, published clinical trials and official government sources. Alsen is not a physician, and his articles are general information, not medical advice.